Viewing nowAtorowojung 10mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Samchundang Pharmaceutical Co., Ltd.

MFDS item code 200709786 · Notified 2007.08.24 · Insurance code 651202710
Improvement of hyperlipidemia (including familial hyperlipidemia) and prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medication is primarily used to reduce the risk of cardiovascular diseases. It is particularly helpful in reducing the risk of conditions such as myocardial infarction, stroke, and angina in adults with cardiovascular risk factors and patients with type 2 diabetes. Additionally, it lowers the risk of myocardial infarction, stroke, need for vascular intervention, hospitalization due to congestive heart failure, and angina in patients already diagnosed with cardiovascular diseases. In patients with hyperlipidemia, it is used to reduce total cholesterol, LDL cholesterol, apo-B protein, and triglyceride levels, while increasing HDL cholesterol levels to improve blood lipid status. Furthermore, it acts as an adjunct to reduce total cholesterol and LDL cholesterol levels in adolescents with familial hypercholesterolemia that is not controlled by diet alone. Thus, this medication is effective for the reduction of cardiovascular disease risk and improvement of dyslipidemia, contributing to the enhancement of patient health.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended starting dose is 10 mg of atorvastatin once daily. However, patients who require a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or greater is required). This medication is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use at the start of treatment and when evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medication is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.
2. Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended starting dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medication greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This medication can cause muscle-related issues, so if symptoms such as muscle pain or weakness occur, treatment should be discontinued immediately and a physician consulted. This medication should not be used in patients with certain liver diseases or severely impaired liver function and regular liver function tests should be performed before and during treatment. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication, and women of childbearing potential should use appropriate contraceptive methods during treatment. This medication should not be used in children under 10 years of age, and should be used cautiously under the judgment of a physician in children aged 10 to 17 years. Patients with a history of alcoholism or liver disease, and those with impaired kidney function, should use this medication with greater caution and require regular monitoring. Interaction may occur when co-administering with other medications, so if currently taking other drugs, it is essential to inform a physician or pharmacist. Caution is required when taken with certain antibiotics, antifungals, antivirals, antihypertensives, and antidiabetics, and particularly when taken with drugs that inhibit CYP3A4 enzymes, as this may increase the risk of side effects. There is no specific antidote for overdose, so the dosage should be strictly adhered to and if any unusual symptoms occur, a medical institution should be visited immediately. This medication should be stored out of reach of children and kept in the original container for safety. If allergic reactions such as skin rashes, hives, itching, or difficulty breathing occur during treatment, stop taking the medication immediately and consult a physician. This medication may raise blood glucose levels, so patients at risk of diabetes should manage their blood sugar carefully, and if severe muscle pain or weakness occurs, they should inform healthcare providers immediately. Elderly patients or those with kidney disease have a higher risk of muscle-related complications and require careful monitoring during treatment. Consuming grapefruit juice can increase the blood concentration of this medication and heighten the risk of side effects, so it is recommended to avoid grapefruit juice.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the efficacy and safety of the medication.
White oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Samchundang Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.